Trials / Completed
CompletedNCT03818113
Clinical Comparative Analysis of Bretschneider and St. Thomas Cardioplegia Solution in Case of Mitral Valve Repair Via Anterolateral Right Thoracotomy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Mitral valve reconstruction via minimal invasive antero- lateral thoracotomy is done in cardioplegia with a cardioplegic solution, either HTK-Bretschneider (Custidiol®) (a crystalloid intracellular solution) or St. Thomas (a crystalloid extracellular solution). This study investigates HTK-Bretschneider versus St. Thomas cardioplegic solution regarding peri- and postoperative outcome, especially for cardiac biomarkers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | cardioplegia with HTK-Bretschneider cardioplegic solution | cardioplegia with HTK-Bretschneider cardioplegic solution |
| OTHER | cardioplegia with St. Thomas cardioplegic solution | cardioplegia with St. Thomas cardioplegic solution |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2019-08-30
- Completion
- 2019-08-30
- First posted
- 2019-01-28
- Last updated
- 2019-11-06
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03818113. Inclusion in this directory is not an endorsement.